Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck – Update 2024
Year: 2025
Type: article
Abstract: ABSTRACT Head-and-neck squamous cell carcinoma (HNSCC) remains a significant public health concern, particularly in India, where its incidence is disproportionately high due to risk factors such as tobacco and alcohol use. The updated guidelines for the management of HNSCC reflect a comprehensive review of current evidence and practices tailored to the Indian context. These emphasize a multidisciplinary approach and the integration of novel therapeutic modalities, including immune checkpoint inhibitors and metronomic chemotherapy. Enhanced diagnostic protocols and a focus on supportive care underscore the commitment to improving patient outcomes and quality of life. This update aims to provide healthcare professionals with clear, evidence-based recommendations that address the unique challenges faced by patients with HNSCC in India.
Institutions: Homi Bhabha National Institute, Tata Memorial Hospital, Indian Air Force, Advanced Centre for Treatment, Research and Education in Cancer, Mazumdar Shaw Medical Centre, Clatterbridge Cancer Centre NHS Foundation Trust, Indraprastha Apollo Hospitals, Rajiv Gandhi Cancer Institute and Research Centre, P. D. Hinduja Hospital and Medical Research Centre, HCG Cancer Hospital, Healthcare Global Enterprises, All India Institute of Medical Sciences
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4414976915